Long-term outcomes and morbidity after I125 brachytherapy for localised prostate cancer: an early UK series

Clin Oncol (R Coll Radiol). 2005 Feb;17(1):68-9. doi: 10.1016/j.clon.2004.09.012.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Brachytherapy / adverse effects*
  • Brachytherapy / methods
  • Disease Progression
  • Humans
  • Iodine Radioisotopes / adverse effects
  • Iodine Radioisotopes / therapeutic use
  • Male
  • Morbidity
  • Neoplasm Staging
  • Patient Selection
  • Perineum
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy*
  • Retrospective Studies
  • Risk Factors
  • Survival Analysis
  • Treatment Outcome

Substances

  • Iodine Radioisotopes